Updates in the management of stable chronic obstructive pulmonary disease

Postgraduate Medicine
Saiprasad NarsingamAsem Abdeljalil

Abstract

Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease state characterized by persistent airflow limitation that is usually progressive and associated with an enhanced chronic inflammatory process. It is increasingly recognized as a major public health problem, affecting more than 20 million adults in the US. It is also recognized as a leading cause of hospitalizations and is the fourth leading cause of death in the US. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) operates to promote evidence-based management of COPD, increase awareness and encourage research. In 2011, GOLD published a consensus report detailing evidence-based management strategies for COPD, which were last updated in 2015. In recent years, newer strategies and a growing number of new pharmacologic agents to treat symptoms of COPD have also been introduced and show promise in improving the management of COPD. We aim to provide an evidence-based review of the available and upcoming pharmacologic and non-pharmacologic treatment options for stable COPD, with continued emphasis on evidence-based management.

References

Mar 4, 1999·The New England Journal of Medicine·D E JorenbyT B Baker
Oct 6, 1999·American Journal of Respiratory and Critical Care Medicine·M J BerryD Zaccaro
Aug 5, 2000·BMJ : British Medical Journal·T LancasterA Sowden
Sep 1, 2000·The European Respiratory Journal·C SteyM R Tramèr
Oct 31, 2002·American Journal of Respiratory and Critical Care Medicine·Paul van der ValkCees van Herwaarden
May 22, 2003·The New England Journal of Medicine·Alfred FishmanUNKNOWN National Emphysema Treatment Trial Research Group
Apr 7, 2004·The European Respiratory Journal·B W M WillemseN H T ten Hacken
Jun 19, 2004·BMJ : British Medical Journal·David AtkinsUNKNOWN GRADE Working Group
Sep 17, 2005·CA: a Cancer Journal for Clinicians·Jack E HenningfieldMaxine L Stitzer
Apr 14, 2006·The European Respiratory Journal·R J HalbertD M Mannino
Jul 6, 2006·JAMA : the Journal of the American Medical Association·David GonzalesUNKNOWN Varenicline Phase 3 Study Group
Aug 29, 2006·Thorax·P J Barnes
Sep 12, 2006·Proceedings of the American Thoracic Society·Scott D Ramsey, F D Richard Hobbs
Feb 21, 2007·Annals of Internal Medicine·Shawn D AaronUNKNOWN Canadian Thoracic Society/Canadian Respiratory Clinical Research Consortium
Feb 23, 2007·The New England Journal of Medicine·Peter M A CalverleyUNKNOWN TORCH investigators
Sep 4, 2007·Lancet·David M Mannino, A Sonia Buist
Oct 6, 2007·American Journal of Respiratory and Critical Care Medicine·Jadwiga A WedzichaUNKNOWN INSPIRE Investigators
Mar 15, 2008·Current Opinion in Pharmacology·Yolanda S López-Boado, Bruce K Rubin
Jun 27, 2008·The European Respiratory Journal·D M ManninoF Holguin
Aug 30, 2008·American Journal of Respiratory and Critical Care Medicine·Terence A R SeemungalJadwiga A Wedzicha
Oct 7, 2008·The New England Journal of Medicine·Donald P TashkinUNKNOWN UPLIFT Study Investigators
Nov 27, 2008·JAMA : the Journal of the American Medical Association·M Bradley DrummondEddy Fan
Aug 1, 2009·American Journal of Respiratory and Critical Care Medicine·Tobias WelteRomain Kessler
Sep 1, 2009·Lancet·Peter M A CalverleyUNKNOWN M2-124 and M2-125 study groups
Sep 1, 2009·Lancet·Sundeep S Salvi, Peter J Barnes
Sep 2, 2009·The European Respiratory Journal·P W JonesN Kline Leidy
Jan 16, 2010·American Journal of Respiratory and Critical Care Medicine·Kathryn L RiceDennis E Niewoehner
Apr 13, 2010·Pulmonary Pharmacology & Therapeutics·Mario Cazzola, Mathieu Molimard
Jul 8, 2010·Chest·James K StollerUNKNOWN Long-term Oxygen Treatment Trial Research Group
Aug 10, 2010·The European Respiratory Journal·O KornmannUNKNOWN INLIGHT-2 (Indacaterol Efficacy Evaluation Using 150-µg Doses with COPD Patients) study investigators
Sep 14, 2010·Respiratory Research·Alvar AgustiUNKNOWN Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators
Sep 24, 2010·The New England Journal of Medicine·Frank C SciurbaUNKNOWN VENT Study Research Group

❮ Previous
Next ❯

Citations

Sep 19, 2018·Respiratory Research·Miriam BarrechegurenMarc Miravitlles

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Cornerstone
Mitchell Friedman
Turkish Journal of Medical Sciences
Duygu ÖzolZeki Yildirim
Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia
Nancy E LaroccaJuan Bautista De Sanctis
© 2021 Meta ULC. All rights reserved